Abstract
In December 2019, the initial reports of a novel coronavirus epidemic emerged in China. Despite South Africa demonstrating determined political efforts to handle the outbreak within its borders, there is currently no established effective treatment for mild cases. The sharing of clinical experiences could prove beneficial in managing emerging infectious diseases. Given the successful management of COVID-19 in China, Traditional Chinese Medicine (TCM) might present a potential solution for mild cases in South Africa, potentially lowering the likelihood of mild cases progressing to severe stages and expediting the recovery process. Data were retrieved from an identified clinic in South Africa between 12 June 2020 to 26 June 2020. All cases were consulted under the regulation of telehealth and telemedicine by using online video consultation. It can be inferred that TCM is efficacious in hastening the recovery process and diminishing the instances of mild cases progressing to severe stages. The utilisation of Chinese herbal medicine proves applicable in treating mild cases of COVID-19, irrespective of variations in geography, climate, and racial factors. This study was constrained in its examination of patients from a single clinic, lacking a comparative aspect. It is advisable that future studies be conducted in more extensive settings to provide a broader perspective.
Publisher
African Centre of Chinese Medicine and Acupuncture
Reference21 articles.
1. Adeloye A. (2020). Self-collected upper respiratory tract swabs for COVID-19 test: A feasible way to increase overall testing rate and conserve resources in South Africa. African Journal of Primary Health Care & Family Medicine, 12(1). https:// doi.org/10.4102/phcfm. v12i1.2445
2. Allied Health Professions Council of South Africa. (2020). Revised Guidelines: Telehealth and Telemedicine as a result of South African State of Disaster. Pretoria: AHPCSA. Available from: https://ahpcsa.co.za/wp-content/uploads/2020/06/ADDENDUM_Q_EXTRAORDINARY_TELEHEALTH_TELEMEDICINE_JUNE2020.pdf)
3. Anonymous. (2016). Huang Di Nei Jing. Beijing: People's Medical Publishing House.
4. Bonilla-Aldana, D.K., Holguin-Rivera, Y., Cortes-Bonilla, I., Cardona-Trujillo, M.C., Garcia-Barco, A., Bedoya-Arias, H.A., Rabaan, A.A., Sah, R., Rodriguez-Morales, A.J. (2020). Coronavirus infections reported by ProMED, February 2000-January 2020. Travel Medicine and Infectious Disease. doi: 10.1016/j.tmaid.2020.101575.
5. Ghebreyesus TA. (2020). Opening Remarks at The Media Briefing on COVID-19, Director General's Speeches. Geneva: World Health Organization.